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Abstract
Background: The dysbiosis of intestinal microbiota has been established in Crohn’s disease (CD), but the molecular
characterization of this dysbiosis in Chinese subjects with CD remains unclear. This study aims to investigate the
predominant bacterial composition of the faecal and mucosal-associated microbiota in Chinese CD patients using culture-
independent techniques.
Methods/Principal Findings: Eighteen patients with CD and 9 healthy controls were included in this study. The faeces and
the intestinal mucosal tissues from the ulcerated and nonulcerated sites were subjected to bacterial community
fingerprinting using denaturing gradient gel electrophoresis (DGGE). The predominant bacterial composition in the faeces
and mucosa was determined with DNA sequencing and BLAST. We showed that the bacterial diversity in the faeces of CD
patients was reduced compared with that in healthy controls (p,0.01). The faecal bacterial dysbiosis of the patients was
characterized by an elevated abundance of c-Proteobacteria (especially Escherichia coli and Shigella flexneri) and a reduced
proportion of Bacteroidetes and Firmicutes. Five bacterial species defined the microbiota imbalance of the ulcerated
mucosa in CD, including an increase in Escherichia coli, a decrease in Faecalibacterium prausnitzii, Lactobacillus coleohominis,
Bacteroides sp and Streptococcus gallolyticus in the bacterial community as compared with the nonulcerated (p,0.01).
Conclusions/Significance: This is the first description of intestinal microbiota dysbiosis in Chinese CD patients. These results
allow a better understanding of the faecal and mucosal microbiota in CD, showing a predominance of some opportunistic
pathogenic bacteria and a decrease in beneficial bacterial species. The findings may provide novel insights into the
pathogenesis of CD in Chinese population.
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Introduction
Crohn’s disease (CD) is a chronic, recurrent inflammatory
disorder of the gastrointestinal tract frequent in Western countries
[1]. In recent years, CD incidence has been increasing in China
[2,3]. However, its aetiology is still unclear. CD is defined as a
complex trait that results from the interaction between the host’s
genetic background and the resident commensal microbiota [4–7].
Recent studies suggest that changes in the gut microbiota play a
part in the pathogenesis of CD [8–10]. The role of the commensal
microbiota in the onset and perpetuation of the intestinal
inflammation in CD is well established [11,12]. A global decrease
in the biodiversity and a markedly reduced diversity of Firmicutes,
and in particular of the Clostridium leptum phylogenetic group are
described as the specificities of the fecal microbiota in CD [13–15].
The composition of the mucosal and faecal microbiota has been
demonstrated to be significantly different [16,17]. The mucosal
microbiota is of particular interest because the mucosal surface is
the site of microbial recognition by the host [18]. CD is a disorder
of mucosal inflammation and the mucosa-associated microbiota
seems of peculiar relevance to the disease process [18,19].
Abnormal composition of mucosa-associated microbiota in
patients with CD has been found [18–20]. CD has increased
amounts of bacteria attached to their gastrointestinal epithelial
surfaces compared with healthy individuals and a proportional
abundance of mucosa-associated Escherichia coli and Pseudomonas
species [21–24]. Faecalibacterium prausnitzii was particularly depleted
in ileocolonic mucosa-associated microbiota in CD [24,25].
The human intestinal microbiota is a complex ecosystem
containing hundreds of microbial species with a density exceeding
10
12 bacteria per gram and it contributes to the host’s nutrition,
intestinal epithelial renewal and development of immune response
[26,27]. It is well established that the pathogenesis of CD is linked
to microbial colonization, host genetics, environmental factors and
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34939immune dysfunction [4,28–30]. Because the composition of the
intestinal microbiota is likely to be influenced by genetic and
environmental factors as well as dietary habits [16,31,32], the
abnormal response of intestinal microbiota in CD might be driven
by the genetic background and dietary custom in the host.
Although supported by little evidence, the composition of
intestinal microbiota in Chinese CD population may differ from
that in Western countries. The changes of intestinal microbiota in
Figure 1. The dysbiosis of faecal microbiota in the patients with Crohn’s disease (CD). (A) Representative DGGE profiles of the faecal
samples from CD patients and healthy controls. CD represents Crohn’s disease patients and HC is healthy controls. (B) Dendrogram illustrating the
similarity correlation of fingerprints between the patients and healthy subjects by means of the clustering algorithm of UPGMA. Scale bar describes
DGGE similarity between profiles.
doi:10.1371/journal.pone.0034939.g001
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However, the characterization of alterations in the composition
and diversity of the intestinal microbiota in CD of Chinese
population remains unknown.
The aim of the current study was to carry out a molecular
analysis on the composition and diversity of the intestinal
microbiota in Chinese patients with CD using denaturing gradient
gel electrophoresis (DGGE) and DNA sequencing. This study was
to compare the microbiological profiles of the faeces from CD
patients and healthy controls and to identify the bacterial species
characteristic of CD patients. We also determined the predomi-
nant bacterial composition of the mucosa-associated microbiota in
the ulcerated ileum of CD patients. Our study was the first to
define the changes of the intestinal microbiota in Chinese CD
patients, which might provide novel knowledge on the role of
intestinal bacterial dysbiosis in CD pathogenesis of Chinese
population.
Figure 2. The plots of principal component analysis of microbiota composition and biodiversity from faecal samples. (A) Principal
component analysis of the DGGE data for the fecal bacterial community compositions of the CD patients and controls. Each circle is representative of
a single sample and shaded according to the abundance of DGGE bands. The plot shows different bacterial community composition in the faeces
from the patients and controls. The percentage of variation explained by each principal component is shown in brackets. (B) Band numbers and
bacterial diversity obtained from the faecal profiles of CD patients. For each group, the mean values and standard deviation (bars) are shown.
Bacterial diversity of CD patients was significantly lower compared with the controls. **, p,0.01.
doi:10.1371/journal.pone.0034939.g002
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Band Closest relative Strain GenBank accession Identity (%)
F1 Helicobacter canadensis MIT 98-5491 hc2 ACSF01000002 99
F2 Acinetobacter lwoffii WJ10621 AFQY01000001 98
F3 Enterococcus faecium TX0133a01 NZ_GL476170 98
F4 Bacteroides sp. 4_1_36 NZ_GL622512 98
F5 Prevotella bryantii B14 NZ_ADWO01000048 98
F6 Clostridium sp. M62/1 NZ_ACFX02000046 98
F7 Faecalibacterium prausnitzii A2-165 NZ_ACOP02000011 100
F8 Veillonella sp. oral taxon 158 str. F0412 NZ_AENU01000007 99
F9 Salmonella enterica subsp. Enterica serovar Kentucky str. CVM29188 NZ_ABAK02000001 99
F10 Ruminococcus flavefaciens FD-1 NZ_ACOK01000111 98
F11 Clostridium bolteae ATCC BAA-613 NZ_ABCC02000039 97
F12 Bacteroides pectinophilus ATCC 43243 NZ_ABVQ01000036 98
F13 Clostridium leptum DSM 753 NZ_ABCB02000017 97
F14 Shigella flexneri J1713 AFOW01000002 99
F15 Escherichia coli PCN033 AFAT01000118 100
F16 Bacteroides coprophilus DSM 18228 NZ_EQ973630 98
F17 Veillonella parvula ATCC 17745 NZ_ADFU01000009 99
F18 Enterobacteriaceae bacterium 9_2_54FAA NZ_ADCU01000033 97
F19 Pseudoflavonifractor capillosus ATCC 29799 NZ_AAXG02000037 97
F20 Veillonella atypica ACS-134-V-Col7a NZ_AEDS01000059 100
F21 Clostridium difficile 6534 ADEJ01001157 100
F22 Veillonella dispar ATCC 17748 NZ_ACIK02000004 99
doi:10.1371/journal.pone.0034939.t001
Table 2. The sequence analysis of DGGE bands from the faeces of controls.
Band Closest relative Strain GenBank accession Identity (%)
H1 Acinetobacter lwoffii WJ10621 AFQY01000001 98
H2 Enterococcus faecium TX0133a01 NZ_GL476170 98
H3 Bacteroides sp. 4_1_36 NZ_GL622512 98
H4 Prevotella bryantii B14 NZ_ADWO01000048 98
H5 Roseburia intestinalis L1-82 NZ_GG692727 97
H6 Clostridium sp. M62/1 NZ_ACFX02000046 98
H7 Faecalibacterium prausnitzii A2-165 NZ_ACOP02000011 100
H8 Bacillus coagulans 36D1 ctg473 NZ_AAWV02000001 98
H9 Veillonella sp. oral taxon 158 str. F0412 NZ_AENU01000007 99
H10 Ruminococcus flavefaciens FD-1 NZ_ACOK01000111 98
H11 Bacteroides pectinophilus ATCC 43243 NZ_ABVQ01000036 98
H12 Bacteroides uniformis ATCC 8492 NZ_AAYH02000029 99
H13 Bacteroides coprophilus DSM 18228 NZ_EQ973630 98
H14 Pseudoflavonifractor capillosus ATCC 29799 NZ_AAXG02000037 98
H15 Clostridium difficile 6534 ADEJ01001157 100
H16 Veillonella dispar ATCC 17748 NZ_ACIK02000004 99
doi:10.1371/journal.pone.0034939.t002
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Patients
Eighteen patients (male/female: 10/8) with ileal CD and 9
healthy subjects (male/female: 5/4) were enrolled in this study.
The median (range) ages were 35.2 (18–58) years for CD group
and 33.7 (20–62) years for the controls. All participants were
native residents in the mainland of China. The diagnosis of CD
was made in accordance with established clinical, endoscopic,
radiological, and histological criteria [33]. Disease activity was
assessed by the Crohn’s disease activity index (CDAI) [34] and all
patients were in an active phase of disease (CDAI.150). Subjects
taking antibiotics or probiotics within 4 weeks before sampling
were excluded from the analyses.
The Ethics Committee for Human Medical Research of Jinling
Hospital approved this study, and all participants gave written
informed consent. Faeces were collected with sterile container
from CD patients and healthy volunteers. The ileal mucosal
specimens including the ulcerated and nonulcerated areas were
surgically obtained from the patients. The tissue specimens were
washed three times with normal saline and then stored at 280uC
for DNA extraction.
DNA Extraction and Polymerase Chain Reaction (PCR)
DNA extraction of faecal samples was performed using a
QIAamp DNA Stool Mini Kit (QIAGEN, Valencia, CA, USA)
according to the manufacturer’s instruction. Mucosa-associated
bacterial DNA was extracted from ileal tissue sections by QIAamp
DNA Mini Kit. The extracted DNA was checked by agarose gel
electrophoresis (1% w/v) and were quantified spectrophotometri-
cally. The hypervariable V3 region of 16S ribosomal RNA gene
was amplified using PCR with universal bacterial primer sets
(F357+GC clamp and R518) [35].
DGGE
DGGE was performed using a DCode universal mutation
system (Bio-Rad, Hercules, CA, USA). The sequence specific
separation of PCR amplicons was conducted on 8% (w/v)
polyacrylamide (acrylamide:bisacrylamide, 37.5:1) gels containing
a urea-formamide gradient from 35 to 55% as previously
described [36]. The electrophoresis was done at 120 V for 7.5 h
at 60uC. The bands were stained with SYBR Green I (Invitrogen,
Carlsbad, CA, USA) and imaged by UV transillumination with
the ChemiDOC
TM XRS instrument (Bio-Rad).
Comparative Analyses of DGGE Profiles
A scanned image of an electrophoretic gel was analyzed using
QuantityOne software (Version 4.2, Bio-Rad). The similarities
between DGGE profiles were assessed by the Dice coefficient and
the unweighted pair group method with the arithmetic average
(UPGMA) clustering algorithm, and the corresponding dendro-
grams were constructed. The relative abundance of each band was
quantified by the staining intensity and was expressed as a
proportion (%) of the sum of all fragments in the same lane of the
gel [37]. The general diversity of bacterial communities was
calculated according to Shannon and Wiener, as described
previously [38,39]. Principal component analysis (PCA) plots were
generated based on the number of DGGE bands using the
multivariate statistics software Canoco (version 4.5, Microcom-
puter Power, Ithaca, NY, USA).
Sequence Alignment and Phylogenetic Analysis
To identify the bacterial species correlated with the bands,
selected products from the stained gels were excised with sterile
scalpels. Gel slices were then incubated in 20 ml of elution buffer
overnight at 4uC. Four ml of the resulting DNA solution was used
as the template for re-amplification and PCR product was checked
by DGGE as described previously [36]. The re-amplified
fragments were purified and subjected to automated sequence
analysis on an ABI PRISM 3730 sequencing system (Applied
Biosystems, Foster City, CA, USA). The retrieved sequences were
compared with the Genbank database using BLAST algorithm.
Phylogenetic trees were generated via a neighbor-joining algo-
rithm from evolutionary distances through the MEGA software
(version 4.0).
Statistical Analysis
Data are presented as means 6 standard deviation (SD).
Statistical analysis was performed by Student’s t test or one-way
analysis of variance (ANOVA) followed by the Holme-Sidak test
using the SPSS software (version 12.0). A p value of less than 0.05
was considered significant.
Figure 3. The relative abundance and frequency of predomi-
nant bacteria in faeces. (A) The mean richness of DGGE bands from
the faecal samples. The staining intensity of fragments was expressed as
a proportion (%) of the sum of all fragments in the same lane. (B)
Frequency of DGGE fragments presented in CD group and the controls.
doi:10.1371/journal.pone.0034939.g003
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34939Figure 4. Comparison of the mucosa-associated microbiota between the ulcerated and nonulcerated ileum. (A) Molecular
fingerprinting of the mucosal bacterial communities. U indicates the ulcerated ileal mucosa and NU is the nonulcerated ileal specimen. (B)
Hierarchical distance clustering of mucosal DGGE profiles from CD patients. The similarities between mucosal specimens are shown in the
dendrogram.
doi:10.1371/journal.pone.0034939.g004
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Shifts in Faecal Bacterial Microbiota
To assess the changes of the composition and diversity in gut
microbiota, the faecal samples from CD patients and healthy
controls were subjected to DGGE analysis. The representative
DGGE profiles were presented in Figure 1A. The dendrogram
based on DGGE banding patterns showed low similarities ranging
from 27% to 42% in faecal bacterial communities between CD
patients and healthy controls. And CD group and the controls
were separated into two different clusters (Fig. 1B). Principal
component analyses, based on the abundance of DGGE bands,
also confirmed that the bacterial community profiles were
distinctly different for the patients and healthy individuals
(Fig. 2A). The data demonstrated large differences in faecal
microbiota composition of CD patients from the healthy controls.
The bacterial diversity, indicated as number of DGGE bands,
was significantly reduced in CD patients compared with that in the
controls (15.062.20 vs.19.962.58, p=0.002) (Fig. 2B). The
alternations of Shannon-Wiener diversity indices according to
Figure 5. The plots of principal component analysis of microbial composition and diversity in mucosa-associated microbiota. (A)
PCA plot of the mucosa-associated microbiota in CD patients. The plot demonstrated the difference of bacterial communities adhered in the
ulcerated and nonulcerated sites. The percentage of variation explained by each principal component is shown in brackets. (B) Biodiversity of
mucosal bacterial microbiota from the ulcerated and nonulcerated ileum. The mean values and standard deviation (bars) are shown. *, p,0.05.
doi:10.1371/journal.pone.0034939.g005
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mean diversity score was 2.1960.13 for the patients and
2.5860.21 for the healthy controls (p=0.005), suggesting that
the biodiversity of faecal microbiota in CD patients was decreased.
The Predominant Bacterial Composition of the Faecal
Microbiota in CD Patients
It has been known that the changes of intestinal bacterial
composition likely contributed to the pathogenesis of CD in
Western population [8–10]. Therefore, we further identified the
alternations of the dominant bacterial species in the faeces of
Chinese CD patients in search of the potential bacteria associated
with CD of Chinese population. Eighty-four sequences of 16S
rRNA gene fragments were obtained from both CD and healthy
faecal samples. These genes fell into 25 different phylotypes based
on the highest sequence similarity (97–100%) matched to
GenBank sequences (Fig. 1A, Tables 1 and 2).
We quantified the relative abundance and frequency of
fragments in DGGE profiles to identify which bacterial species
might be involved in CD (Fig. 3). As shown in Fig. 3A and
Table S1, the proportions of c-Proteobacteria phylum, including
Escherichia coli (F15), Shigella flexneri (F14), Enterobacteriaceae bacterium
(F18) and Salmonella enterica (F9), were significantly increased in
the patients as comparison with the control group (p,0.01). In
contrast, most of Firmicutes bacteria detected in the faeces, such as
Faecalibacterium prausnitzii (F7), Clostridium sp. (F6), Ruminococcus
flavefaciens (F10), Enterococcus faecium (H2), Roseburia intestinalis (H5)
and Bacillus coagulans (H8), showed a reduction in relative richness
in the faecal microbiota of CD patients (p,0.01). However,
Clostridium bolteae (F11) and Clostridium leptum (F13) were more
abundant in CD patients than that in the controls (p,0.01). In
addition, four bacteria of Bacteroidetes, Bacteroides sp. (H3),
Bacteroides pectinophilus (H11), Bacteroides uniformis (H12) and Prevotella
bryantii (H4) which dominated the faecal microbiota in the control
group, were few present in CD patients (p,0.01). These results
suggested that some opportunistic pathogenic c-Proteobacteria
greatly increased and became to be predominant in the faeces of
CD patients instead of Bacteroides and Firmicutes. Analysis of
sequence pools revealed significant differences in microbial
community composition between CD patients and controls.
The Mucosa-associated Microbiota in Ulcerated and
Nonulcerated Areas
It is important to note that the mucosal and faecal microbiota
consist of distinct bacterial populations, and mucosa-associated
microbes may be more important in CD pathogenesis [18,19]. We
profiled the bacterial composition and diversity in ileal mucosal
specimens from the ulcerated and nonulcerated regions in CD
patients (Fig. 4A). As shown in Figure 4B, the nonulcerated
mucosal samples between different patients displayed higher
Figure 6. The relative richness and frequency of predominant
microorganisms in mucosal specimens. (A) Changes in the relative
abundance of fragments from the ulcerated and nonulcerated
specimens. (B) The frequency of DGGE bands presented in the
ulcerated and nonulcerated ileum.
doi:10.1371/journal.pone.0034939.g006
Table 3. The sequence analysis of DGGE bands from mucosal samples.
Band Closest relative Strain GenBank accession Identity (%)
M1 Streptococcus gallolyticus subsp. gallolyticus TX20005 NZ_AEEM01000001 98
M2 Bacteroides sp. 4_1_36 NZ_GL622512 98
M3 Clostridium sp. M62/1 NZ_ACFX02000046 99
M4 Bacillus coagulans 36D1 ctg473 NZ_AAWV02000001 99
M5 Faecalibacterium prausnitzii A2-165 NZ_ACOP02000011 100
M6 Lactobacillus coleohominis 101-4-CHN NZ_GG698808 98
M7 Clostridium leptum DSM 753 NZ_ABCB02000017 98
M8 Yersinia enterocolitica subsp. palearctica YO527 CACW01000009 98
M9 Escherichia coli PCN033 AFAT01000118 100
M10 Clostridium difficile 6534 ADEJ01001157 100
doi:10.1371/journal.pone.0034939.t003
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However, the banding patterns of the ulcerated mucosa were
different from those in the nonulcerated tissues with lower
similarities from 54% to 64%. The PCA plot clearly showed that
the bacterial community composition was distinct between the
ulcerated and nonulcerated specimens for both the first and the
second principal component (Fig. 5A). Noticeably, the number of
DGGE bands was fewer in the ulcerated mucosa (15.062.45) than
that in the nonulcerated mucosa (18.361.21, p=0.023) (Fig. 5B),
suggesting a reduced diversity of bacterial community in the
ulcerated areas in CD. Our results revealed that the mucosa-
associated bacterial composition and diversity in the ulcerated
regions was differentiated from the nonulcerated mucosa in CD.
The Bacterial Phylotypes Adhered in Ulcerated and
Nonulcerated Mucosa
For a better understanding of the potential involvement
between the mucosa-associated microbiota and CD, we next
sought to determine the shifts of predominant bacterial compo-
sition in the intestinal mucosa of CD individuals (Fig. 6). Ten
bacterial phylotypes were identified using DNA sequencing and
BLAST analysis (Fig. 4A, Table 3) and the significant alternations
in the richness were found between the ulcerated and nonulcer-
ated specimens (Fig. 6A, Table S2). We observed that the relative
abundance of Escherichia coli (M9), Clostridium difficile (M10),
Clostridium sp. (M3) and Clostridium leptum (M7) were much higher
in the ulcerated group than that in the nonulcerated (p,0.01)
(Fig. 6A, Table S2). The intensity of four bands corresponding to
Faecalibacterium prausnitzii (M5), Lactobacillus coleohominis (M6),
Bacteroides sp. (M2) and Streptococcus gallolyticus (M1), was decreased
significantly in the ulcerated mucosa compared with that in the
control regions (p,0.01). It indicated that the elevated proportion
of some opportunistic pathogenic bacteria might be associated
with the inflammatory response and the formation of mucosal
ulceration in CD (Fig. 7).
Phylogenetic Analysis of the Predominant Bacteria
The sequences representing the respectivelyexcised DGGEbands
were phylogenetically analyzed by ClustalW and neighbor-joining
alignment.The phylogeneticdendrogramshowedthat thedominant
sequences fromthe faecesinCD patients were divided into 4 clusters
(Fig. 8): Firmicutes (total 12 sequences: 7 of Clostridiales; 1 of
Lactobacillales, 4 of others), Bacteroidetes (total 4 sequences, 4 of
Bacteroidales), c-Proteobacteria (total 5 sequences: 4 of Enterobac-
teriales,1 of others)ande-Proteobacteria (1sequence).Inthe healthy
controls, the sequences were belonged to 3 clusters: Firmicutes (total
10 sequences: 6 of Clostridiales; 1 of Lactobacillales, 1 of Bacillales, 1
of others), Bacteroidetes (total 5 sequences: 5 of Bacteroidales), c-
Proteobacteria (1 sequence, 1 of Enterobacteriales). It revealed that
the predominant bacterial composition in the faeces was altered and
the Proteobacteriaphylum wasoverrepresented inpatientswithCD.
Ten dominant sequences obtained from the mucosal specimens
were phylogenetically clustered into 3 phylum (Fig. 9): Firmicutes
(total 7 sequences: 4 of Clostridiales; 2 of Lactobacillales, 1 of
Bacillales), Bacteroidetes (Bacteroidales: 1 sequence) and c-
Proteobacteria (2 sequences, 2 of Enterobacteriales:). The
dominant mucosa-associated microbiota showed greater differ-
ences from the dominant fecal microbiota in CD patients.
Discussion
In this study, we used culture-independent techniques to
characterize the intestinal microbiota dysbiosis in the faeces and
ileal mucosa of Chinese patients with CD. Cluster analysis of the
bacterial profiles in faecal samples showed distinct clustering of
CD patients and controls. The biodiversity of faecal microbiota
was reduced in CD patients. The dysbiosis signature we found in
Chinese patients with CD was markedly characteristic by an
increase of the richness of some opportunistic pathogenic c-
Proteobacteria (especially Escherichia coli and Shigella flexneri) and a
decrease of the proportion of Firmicutes and Bacteroides. The
profiles of the mucosa-associated microbiota in CD patients
demonstrated that the predominant composition of bacteria
attached to the ulcerated mucosa was distinguishable from that
in the nonulcerated area. The diversity of the microbiota in the
ulcerated sites was decreased in comparison to that in the
nonulcerated mucosa. The relative abundance of Escherichia coli
and Clostridium spp. were found to be much higher in the ulcerated
Figure 7. Histological characteristics of the ileal mucosa from CD patient. H&E staining showed normal epithelial architecture and few
infiltrated inflammatory cells in the nonulcerated tissues (A). The mucosal specimen from ulcerated ileum revealed the disrupted mucosal
architecture and the infiltration of inflammatory cells in (B). Magnifications: 6100.
doi:10.1371/journal.pone.0034939.g007
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Lactobacillus coleohominis, Bacteroides sp. and Streptococcus gallolyticus
were decreased significantly in the richness in the ulcerated
mucosa. Our study demonstrated the molecular characteristic of
the intestinal microbiota dysbiosis in the faeces and the mucosal
tissues in Chinese population with CD.
Previous studies have provided evidence of the roles of the
intestinal microbiota in the development and/or progression of
CD [8–10]. The intestinal microbiota of patients with both active
and inactive CD differs from that of healthy subjects [20].
However, the dysbiosis of intestinal bacterial community in
Chinese CD patients is still unknown. In the present study, we
profiled the bacterial composition and diversity of the fecal
samples obtained from Chinese patients with CD. Large
differences in the fecal microbiota were presented between the
individuals with CD and healthy controls. We showed a reduced
bacterial diversity in CD individuals compared to healthy controls,
which was consistent with numerous other reports in Western
populations with CD [14,15]. This is the first finding that
specifically pointed to a lower diversity for Chinese population
subjects with CD.
Sequence analysis of 16S rRNA gene fragments provided the
detailed description of the bacterial composition in the faeces of
CD patients. Our results showed that the dominant bacterial
species were altered in the faeces of CD patients, which was
characterized by an overrepresentation of c-Proteobacteria and a
relative lack of Firmicutes and Bacteroidetes phylum. We observed
that Escherichia coli, a major member of c-Proteobacteria, had a
significantly elevated abundance and became to be dominant in
the faeces from CD patients. This finding corroborated recent
researches suggesting a possible link between Escherichia coli and the
pathogenesis of CD [21–23,40,41]. Our another important finding
was a decreased proportion of Firmicutes phylum, in particular of
Faecalibacterium prausnitzii in the faecal microbiota of CD patients.
Faecalibacterium prausnitzii has been known as a potent anti-
inflammatory commensal organism [42]. Our data suggested that
Faecalibacterium prausnitzii might be negatively associated with CD,
which was consistent with the results of previous studies
[24,25,42]. The other members of Firmicutes, including Clostridium
sp. Ruminococcus flavefaciens, Enterococcus faecium, Roseburia intestinalis
and Bacillus coagulans were also observed markedly decreased in the
faeces in CD patients. These Gram positive anaerobic bacteria
usually account for a major fraction of the faecal microbiota in
healthy subjects [31]. The data indicated that a reduced richness
of Firmicutes might be implicated in the pathogenesis of CD. In
addition, the quantitative composition of Bacteroides spp. popula-
Figure 9. Phylogenetic relationship of 16S rDNA sequences obtained from the mucosal specimens of CD patients. The sequences
were aligned with reference strains obtained from the GenBank database. Ten predominant bacterial species from the mucosal specimens were
phylogenetically clustered into 3 phylum: Firmicutes, Bacteroidetes and c-Proteobacteria. The scale bar represents the genetic distance.
doi:10.1371/journal.pone.0034939.g009
Figure 8. Phylogenetic tree generated from the 16S rDNA sequences of predominant bacterial species in the faeces. The sequences
were aligned with closely related 16S rDNA sequences retrieved from GenBank database using the BLAST. The dominant sequences from the faeces
of CD patients and healthy subjects were divided into 4 clusters: Firmicutes, Bacteroidetes, c-Proteobacteria and e-Proteobacteria. The scale bar
represents the genetic distance.
doi:10.1371/journal.pone.0034939.g008
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normal controls. Seksik et al. also found a decreased population
level of Bacteroidetes in the faeces from CD patients [17]. A
group-specific molecular analysis showed a significant low diversity
of Bacteroides in the faecal microbiota of CD patients [18,19].
However, the studies of Bacteroidets in CD are still controversial.
Several culture studies have shown a possible increase of Bacteroides
spp. population level in CD [43,44].
Apart from that, we demonstrated some unique characteristics
of faecal bacterial imbalance in Chinese CD patients. We found
that Shigella flexneri was more prevalent and abundant in CD
patients but not present in healthy individuals. Some opportunistic
pathogenic Proteobacteria such as Enterobacteriaceae bacterium,
Salmonella enterica and Helicobacter Canadensis were also found
occasionally in CD patients. These bacterial species were all
absent from the previous investigation of CD. In addition, an
elevated richness of Clostridium bolteae and Clostridium leptum was
detected in CD patients and it was not consistent with the previous
results. It was usually thought that the Clostridium phylogenetic
group, especially Clostridium leptum subgroup, was low abundant in
CD patients compared with the healthy subjects [13,17]. Veillonella
dispar and Veillonella sp. that was abundant in healthy controls were
absent from the dominant biota of CD patients (p,0.01; Fig. 1A,
Table S1), which was few involved in CD in previous studies.
These findings appeared different from the results obtained from
Western subjects with CD. It has been known that the composition
of intestinal microbiota is influenced by genetic background and
food custom [31,32,45,46]. Previous study has reported that the
variants of NOD2 and other IBD genes in Chinese CD patients
were distinct from Western CD patients [47]. So it was probable
that human genetic background might be responsible for the
differences of intestinal microbiota in Chinese patients. Further-
more, different dietary habits might be another important reason
for the variations of intestinal microbiota between Chinese and
Western subjects [48,49]. Our current data might provide new
bacterial species linked to active CD in China.
A relationship between disturbed microbiota and mucosal
inflammation has not been established. Because mucosa-associated
microbial species is close proximity to the host epithelium, the
bacteria attached in intestinal mucosa are more likely to be
involved in the inflammatory response of the gut than the luminal
counterparts [18,19]. It has been recognized that the intestinal
mucosa-associated microbiota differs substantially from the fecal
microbiota [16,18]. However, the mucosa-associated microbiota
in CD is poorly known, especially for inflammatory settings in CD
patients. In this study, we used molecular phylogenetic analysis to
characterize the mucosal microbiota and compared the differences
of predominant bacterial composition between the ulcerated and
nonulcerated tissues in the patients with ileal CD. As expected
from previous studies of the mucosa-associated microbiota in
Western CD subjects [18–20], we observed a decreased biodiver-
sity of bacteria biota in the ulcerated mucosa in Chinese patients.
The dominant bacterial structures in the ulcerated and the
nonulcerated tissues showed low similarity, which were not in
agreement with previous work [50]. Although the prevalence of
the predominant microbial species were similar (Fig. 6B), their
relative abundance was shifted in the ulcerated mucosa as
compared with the nonulcerated areas (Fig. 6A), which was a
major contributor for the lower similarity between the two
different sites. The quantitative analysis of 16S rDNA fragments
showed that Escherichia coli was more abundant in the ulcerated
sites of intestinal mucosa than that in the nonulcerated mucosa.
Increased abundance of Escherichia coli in biopsies from CD
patients has previously been reported [13,16,19,21–24]. These
findings indicated that Escherichia coli was specifically associated
with ulceration in CD patients [21–23]. Similar to previous results
obtained from Western CD patients [24,25], Faecalibacterium
prausnitzii were less dominant in ulcerated mucosa in CD patients.
In addition, the relative richness of Bacteroides sp., Lactobacillus
coleohominis and Streptococcus gallolyticus were decreased significantly
in the ulcerated mucosa, which was few detected in mucosa-
associated microbiota in the previous study. The decreased
richness of these bacterial species may be resulted from the
overgrowth of the pathogens attached in the ulcerated sites. These
differences between the ulcerated and the nonulcerated mucosa
may reflect the altered nature of the mucus present on the mucosal
surface of CD patients. The bacterial dysbiosis in the ulcerated
mucosa of CD patients may be closely associated to the
inflammatory response and disrupted mucosal structure seen in
CD patients (Fig. 7).
In summary, we reported the results of a prospective study on
intestinal microbiota in Chinese patients with CD. The present
study defined for the first time the molecular characteristics of
intestinal microbiota dysbiosis in Chinese CD subjects. We
identified a reduced biodiversity of faecal bacterial community
in CD. The faecal bacterial dysbiosis in CD patients was
characterized by an increase of the richness c-Proteobacteria
(especially Escherichia coli and Shigella flexneri) and a reduced
proportion of Bacteroides and Firmicutes. For mucosa-associated
microbiota, we demonstrated a decrease of bacterial diversity in
the ulcerated mucosa compared with that in the nonulcerated
sites. In addition, the quantitative composition of the bacteria
adhered to the ulcerated areas was different from that in the
nonulcerated mucosa, which was mainly characteristic by an
elevated Escherichia coli level and a reduction of Faecalibacterium
prausnitzii, Lactobacillus coleohominis, Bacteroides sp and Streptococcus
gallolyticus in the ulcerated sites. Taken together, we demonstrated
an overrepresentation of some opportunistic pathogenic bacteria
and a decrease in beneficial bacterial species in intestinal
microbiota of Chinese CD patients, which indicated a possible
relationship between some bacteria and the origin of CD. These
findings may provide new clues into determining the aetiological
mechanisms of CD in China.
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